Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2012
The primary purpose of this study is to assess the immune response to vitamin D supplementation at two doses (5,000 IU and 10,000 IU daily) in both healthy controls and patients with clinically isolated syndrome compared to placebo. Secondary endpoints include (1) disease outcome in the clinically isolated syndrome in terms of clinical relapses and evidence of new lesions on MRI (McDonald\'s MS), 2) Safety of doses used
Epistemonikos ID: a9f2abc197f15f85af4c8ff8d27e4a6a4fd96970
First added on: Mar 31, 2022